Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study
Clinical and Molecular Hepatology · 2023
DOI: 10.3350/cmh.2023.0110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, 2023. Verfasst von Chang Hun Lee und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk Nati…. Hauptthemen laut MEDLINE: Hepatitis B, Hepatitis C, Liver Neoplasms, Hepatitis, Viral, Human. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Korea Disease Control and Prevention Agency, National Research Foundation of Korea, Ministry of Science, ICT and Future Planning.
Abstract (Originalsprache)
Background/Aims: To eliminate hepatitis B virus (HBV) and hepatitis C virus (HCV) according to the World Health Organization (WHO) criteria in 2021, this study investigated the national core indicators representing the current status of viral hepatitis B and C in South Korea.
Methods
We analyzed the incidence, linkage-to-care, treatment, and mortality rates of HBV and HCV infection using the integrated nationwide big data of South Korea.
Results
According to data from 2018–2020, the incidence of acute HBV infection in South Korea was 0.71 cases per 100,000 population; tthe linkage-to-care rate was only 39.4%. Among those who need hepatitis B treatment, the treatment rate was 67.3%, which was less than 80% reported in the WHO program index. The annual liver-related mortality due to HBV was 18.85 cases per 100,000 population, exceeding the WHO target of four; the most frequent cause of death was liver cancer (54.1%). The annual incidence of newly diagnosed HCV infection was 11.9 cases per 100,000 population, which was higher than the WHO impact target of five. Among HCV-infected patients, the linkage-to-care rate was 65.5% while the treatment rate was 56.8%, which were below the targets of 90% and 80%, respectively. The liver-related annual mortality rate due to HCV infection was 2.02 cases per 100,000 population.
Conclusions
Many of the current indicators identified in the Korean population did not satisfy the WHO criteria for validation of viral hepatitis elimination. Hence, a comprehensive national strategy should be urgently developed with continuous monitoring of the targets in South Korea.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonbuk National University Medical School,…
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
- Cancer Control and Population Health, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.
- Department of Internal Medicine, Uijeongbu Eulji Medical Center, Eulji University School of Medicine, Uijeongbu, Korea.
- Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
- Department of Internal Medicine, Institute for Digestive Research, Digestive Disease Center, Soonchunhyang University College of Medicine, Seoul, Korea.
Förderung
- Korea Disease Control and Prevention Agency
- National Research Foundation of Korea
- Ministry of Science, ICT and Future Planning
Zitieren
APA
Lee, C. H., Choi, G. H., Choi, H. Y., Han, S., Jang, E. S., Chon, Y. E., Chang, Y., Kim, K. A., Kim, D. Y., Yim, H. J., Kim, H. L., Jeong, S. H., & Kim, I. H. (2023). Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2023.0110
Vancouver
Lee CH, Choi GH, Choi HY, Han S, Jang ES, Chon YE, et al. Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study. Clinical and Molecular Hepatology. 2023. doi:10.3350/cmh.2023.0110
BibTeX
@article{Lee2023,
author = {Lee, Chang Hun and Choi, Gwang Hyeon and Choi, Hwa Young and Han, Sojung and Jang, Eun Sun and Chon, Young Eun and Chang, Young and Kim, Kyung-Ah and Kim, Do Young and Yim, Hyung Joon and Kim, Hye-Lin and Jeong, Sook-Hyang and Kim, In Hee},
title = {Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study},
journal = {Clinical and Molecular Hepatology},
year = {2023},
doi = {10.3350/cmh.2023.0110}
}
EUVIMED